Defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 2, 2014, Pages 337-346

  Russo, Andrea M ^a   Chung, Mina K ^b  

^a Department of Anesthesiology   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Arrhythmias; Cardiac; Defibrillators; Implantable; Ventricular fibrillation

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; CONVULSIVE THERAPY; DEFIBRILLATION; DEFIBRILLATION TESTING; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG TERM SURVIVAL; MEDICAL DEVICE COMPLICATION; NONISCHEMIC CARDIOMYOPATHY; OBSERVATIONAL STUDY; ORGAN PERFUSION; PEROPERATIVE COMPLICATION; PNEUMOTHORAX; POST HOC ANALYSIS; PRIORITY JOURNAL; R WAVE; RESPIRATION DEPRESSION; SINUS RHYTHM; SUDDEN CARDIAC DEATH; SUPERIOR CAVA VEIN; THORACOTOMY; TRANSIENT ISCHEMIC ATTACK; WAVEFORM;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; VENTRICULAR FIBRILLATION;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; UNNECESSARY PROCEDURES; VENTRICULAR FIBRILLATION;

EID: 84899697423     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000371     Document Type: Article

References (79)

1. Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J. 1997;337:1576-1583.
2. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-2078.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890.
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
8. Neuzner J, Pitschner HF, Huth C, Schlepper M. Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans. Pacing Clin Electrophysiol. 1994;17:207-212.
9. Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996;78:540-543.
10. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. J Am Coll Cardiol. 1996;28:400-410.
11. Natale A, Sra J, Axtell K, Maglio C, Dhala A, Deshpande S, Jazayeri M, Wase A, Akhtar M. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system. J Am Coll Cardiol. 1994;24:406-412.
12. Rattes MF, Jones DL, Sharma AD, Klein GJ. Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate. Pacing Clin Electrophysiol. 1987;10(1 Pt 1):70-77.
13. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol. 1992;15:932-949.
14. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC 3rd. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol. 1988;62:393-398.
15. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol. 2007;30:675-700.
16. Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol. 1992;70:1017-1022.
17. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation. 2001;103:2159-2164.
18. Sauer WH, Lowery CM, Bargas RL, Schuller JL, Stees CS, Aleong RG, Varosy PD. Utility of postoperative testing of implantable cardioverter-defibrillators. Pacing Clin Electrophysiol. 2011;34:186-192.
19. Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR; INTRINSIC RV Study Investigators. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace. 2008;10:347-350.
20. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm. 2005;2:456-461.
21. Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS, Dorian P, Chen Z, Cameron D, Verma A, Connolly SJ, Gula LJ, Lockwood E, Nair G, Tu JV; Ontario ICD Database Investigators. Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry. J Cardiovasc Electrophysiol. 2010;21:1344-1348.
22. Keyser A, Hilker MK, Schmidt S, von Bary C, Zink W, Ried M, Schmid C, Diez C. Shock or no shock- A question of philosophy or should intraoperative implantable cardioverter defibrillator testing be recommended? Interact Cardiovasc Thorac Surg. 2013;16:321-325.
23. Vischer AS, Sticherling C, Kühne MS, Osswald S, Schaer BA. Role of defibrillation threshold testing in the contemporary defibrillator patient population. J Cardiovasc Electrophysiol. 2013;24:437-441.
24. L in EF, Dalal D, Cheng A, Marine JE, Nazarian S, Sinha S, Spragg DD, Tandri H, Halperin H, Calkins H, Berger RD, Tomaselli GF, Henrikson CA. Predictors of high defibrillation threshold in the modern era. Pacing Clin Electrophysiol. 2013;36:231-237.
25. Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS. A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial. J Cardiovasc Electrophysiol. 2012;23:1313-1316.
26. Havel WJ, Johnson J. Effect of number of shock coils on defibrillation testing outcome: analysis from the Medtronic Discovery™ Hub database. Heart Rhythm. 2010;7:S75.
27. Mainigi SK, Cooper JM, Russo AM, Nayak HM, Lin D, Dixit S, Gerstenfeld EP, Hsia HH, Callans DJ, Marchlinski FE, Verdino RJ. Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm. 2006;3:1010-1016.
28. Leong-Sit P, Gula LJ, Diamantouros P, Krahn AD, Skanes AC, Yee R, Klein GJ. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Am Heart J. 2006;152:1104-1108.
29. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol. 2008;52:551-556.
30. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553-1561.
31. Shukla HH, Flaker GC, Jayam V, Roberts D. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol. 2003;26(1 Pt 1):44-48.
32. Khalighi K, Daly B, Leino EV, Shorofsky SR, Kavesh NG, Peters RW, Gold MR. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol. 1997;79:150-153.
33. Brooks R, Garan H, Torchiana D, Vlahakes GJ, Jackson G, Newell J, McGovern BA, Ruskin JN. Determinants of successful nonthoracotomy cardioverter-defibrillator implantation: experience in 101 patients using two different lead systems. J Am Coll Cardiol. 1993;22:1835-1842.
34. Jain SK, Ghanbari H, Hourani R, Larsen TR, Daccarett M, Machado C. Echocardiographic parameters to predict inadequate defibrillation safety margin in patients receiving implantable cardioverter defibrillators for primary prevention. J Interv Card Electrophysiol. 2013;37:79-85.
35. Raitt MH, Johnson G, Dolack GL, Poole JE, Kudenchuk PJ, Bardy GH. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol. 1995;25:1576-1583.
36. Russo AM, Al-Khatib SM, Wang Y, Curtis J, Marcus GM, Hsu JC, Sood N, Parker MW, Kluger J, Lampert R. Predictors of high defibrillation energy requirements: results from the NCDR ICD Registry. Circulation. 2012;126(suppl):A9039.
37. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation. 1992;86:1206-1216.
38. Flaker GC, Tummala R, Wilson J. Comparison of right-and left-sided pectoral implantation parameters with the Jewel active can cardiodefibrillator. The World Wide Jewel Investigators. Pacing Clin Electrophysiol. 1998;21:447-451.
39. Roberts PR, Allen S, Betts T, Morgan JM, Urban JF, Whitman T, Euler DE, Roberts PR, Allen S, Betts T, Morgan JM, Urban JF, Whitman T, Euler DE. Increased defibrillation threshold with right-sided active pectoral can. J Interv Card Electrophysiol. 2000;4:245-249.
40. Roberts BD, Hood RE, Saba MM, Dickfeld TM, Saliaris AP, Shorofsky SR. Defibrillation threshold testing in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33:1342-1346.
41. Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation. 2006;114:104-109.
42. Pelosi F Jr, Oral H, Kim MH, Sticherling C, Horwood L, Knight BP, Michaud GF, Morady F, Strickberger SA. Effect of chronic amiodarone therapy on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol. 2000;11:736-740.
43. Dorian P. Amiodarone and defibrillation thresholds: a clinical conundrum. J Cardiovasc Electrophysiol. 2000;11:741-743.
44. Verma A, Kaplan AJ, Sarak B, Oosthuizen R, Beardsall M, Higgenbottam J, Wulffhart Z, Khaykin Y. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation. J Interv Card Electrophysiol. 2010;29:127-133.
45. Hodgson DM, Olsovsky MR, Shorofsky SR, Daly B, Gold MR. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol. 2002;25(4 Pt 1):408-413.
46. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, Payne J, Strickberger SA, Breiter D, Hahn S. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation. 2002;105:2043-2048.
47. Sweeney M, DeGroot P, Stark A, Otterness M, Buxton A, Wathen M, Investigators PRI. Relationship between defibrillation threshold, programmed energy and first shock efficacy for fast ventricular tachycardia and ventricular fibrillation in PainFRE Rx II. Circulation. 2004;110:II-503A.
48. Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol. 2006;17:140-145.
49. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol. 2002;39:1323-1328.
50. Babbs CF, Tacker WA, VanVleet JF, Bourland JD, Geddes LA. Therapeutic indices for transchest defibrillator shocks: effective, damaging, and lethal electrical doses. Am Heart J. 1980;99:734-738.
51. Wilson CM, Allen JD, Bridges JB, Adgey AA. Death and damage caused by multiple direct current shocks: studies in an animal model. Eur Heart J. 1988;9:1257-1265.
52. Bun SS, Duytschaever M, Tavernier R. Defibrillation testing can reveal 'concealed' lead fracture. Europace. 2013;15:54.
53. Doshi R, Ceballos S, Mendez F. Is high-voltage lead integrity measurement adequate during defibrillator generator replacement? Journal of Innovations in Cardiac Rhythm Management. 2012;3:1016-1019.
54. Shah P, Singh G, Chandra S, Schuger CD. Failure to deliver therapy by a Riata Lead with internal wire externalization and normal electrical parameters during routine interrogation. J Cardiovasc Electrophysiol. 2013;24:94-96.
55. Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Higgins SL, Klein H, Pfeffer M, Wilber D, Zareba W. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10(4 Suppl):34-43.
56. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo L, Echt DS, Packer D, Greer GS, Talajic M. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis. 1993;36:215-226.
57. Schuger C, Ellengoben KA, Faddis M, Knight BP, Yong P, Sample R. Defibrilllation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2006;17:247-250.
58. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-932.
59. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4:1260-1263.
60. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, Parkash R, Khaykin Y, Philippon F, Guerra P, Kimber S, Cameron D, Healey JS. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm. 2008;5:387-390.
61. Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D'Acri MG, Klersy C, Gasparini M; SAFE-ICD Study Investigators. Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol. 2012;60:981-987.
62. Russo A, Wang Y, Curtis J, Al-Khatib, S, Lampert R. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter insertion: findings of the NCDR®. Pacing Clin Electrophysiol. 2013;36:1522-1531.
63. Pires LA, Hull ML, Nino CL, May LM, Ganji JR. Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: terminal events, predictors, and potential mechanisms. J Cardiovasc Electrophysiol. 1999;10:1049-1056.
64. Codner P, Nevzorov R, Kusniec J, Haim M, Zabarski R, Strasberg B. Implantable cardioverter defibrillator with and without defibrillation threshold testing. Isr Med Assoc J. 2012;14:343-346.
65. Michowitz Y, Lellouche N, Contractor T, Bourke T, Wiener I, Buch E, Boyle N, Bersohn M, Shivkumar K. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace. 2011;13:683-688.
66. Hall B, Jeevanantham V, Levine E, Daubert J, McNitt S, Hall F, Jeevanantham V, Levine E, Daubert J, McNitt S, Hall FM, Jeevanantham V, Levine E, Daubert J, McNitt S, Morady FM, Pelosi F. Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing. Cardiol J. 2007;14:463-469.
67. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt MH. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2011;8:1881-1886.
68. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
69. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365.
70. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-562.
71. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
72. Aktas MK, Huang DT, Daubert JP, Schuger CD, McNitt S, Goldenberg I, Moss AJ, Zareba W. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm. 2013;10:193-199.
73. Bhavnani SP, Kluger J, Coleman CI, White CM, Guertin D, Shafi NA, Yarlagadda RK, Clyne CA. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm. 2010;7:755-760.
74. Russo AM, Gerstenfeld EP, Dixit S, Leong-Sit P, Hutchinson M, Riley M, Bala R, Garcia F, Lin D, Verdino RJ, Cooper J, Patel V, Callans DJ, Marchlinski FE. Changing patterns of defibrillation testing at the time of implantable cardioverter defibrillator insertion over the past 8 years. J Am Coll Cardiol. 2009;53(suppl):A134.
75. Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, Grammatico A, De Santo T, Santi E, Merico M, Piccirillo G, Azzolini P, Santini M, Puglisi A. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol. 2009;32:573-578.
76. Stefano B, Pietro RR, Maurizio G, Maurizio L, Renato M, Maurizio L, Pietro R, Alessandro P, Gianluca B, Monica M, Sergio C, Massimo S. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project. Am Heart J. 2011;162:390-397.
77. Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M, Luise R, Occhetta E, Proclemer A. Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nationwide survey. Europace. 2007;9:540-543.
78. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Viñolas X, Mabo P, Kautzner J, O'Hara G, Van Erven L, Gadler F, Appl U, Connolly SJ. The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation. Am Heart J. 2012;164:146-152.
79. Fisher JD. Defibrillation testing: philosophy and science. Pacing Clin Electrophysiol. 2011;34:185.